InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Browse the complete record of transactions filed by Kim Paul, Chief Financial Officer. Insider active across 1 companies, notably Fulgent Genetics, Inc.. Aggregated, 32 filings have been published. Total volume traded: €3.7m. The latest transaction was filed on 26 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations32 total
US$24,4771,168 shares@ US$20.95610.0055% mcap100.0% of flow
Common Stock
SEC:0001253820-26-000001·
€24,4771,168 shares@ €20.95610.0055% mcap50.0% of flow
Common Stock
SEC:0001253820-26-000001:0·
€21,270415 shares@ €51.25260.0048% mcap0.4% of flow
Common Stock
SEC:0001209191-22-034511:0·
€16,620325 shares@ €51.13760.0037% mcap0.3% of flow
Common Stock
SEC:0001209191-22-030070:0·
€43,398806 shares@ €53.84420.0097% mcap0.9% of flow
Common Stock
SEC:0001209191-22-027378:0·
€23,005454 shares@ €50.67170.0052% mcap0.5% of flow
Common Stock
SEC:0001209191-22-016456:0·
09,000 shares0
Common Stock
SEC:0001209191-22-014769:0·
€17,819303 shares@ €58.80770.0040% mcap0.4% of flow
Common Stock
SEC:0001209191-22-010889:0·
€45,043806 shares@ €55.88520.010% mcap1.9% of flow
Common Stock
SEC:0001209191-22-007469·
€45,043806 shares@ €55.88520.010% mcap0.9% of flow
Common Stock
SEC:0001209191-22-007469:0·
04,000 shares0
Common Stock
SEC:0001209191-22-001996:0·
04,000 shares0
Common Stock
SEC:0001209191-22-001996·
€45,548620 shares@ €73.46430.010% mcap1.9% of flow
Common Stock
SEC:0001209191-21-068107·
€45,548620 shares@ €73.46430.010% mcap0.9% of flow
Common Stock
SEC:0001209191-21-068107:0·
€861,62510,263 shares@ €83.95450.19% mcap36.3% of flow
Common Stock
SEC:0001209191-21-066399·
€861,62510,263 shares@ €83.95450.19% mcap17.7% of flow
Common Stock
SEC:0001209191-21-066399:0·
€38,229455 shares@ €84.02080.0086% mcap1.6% of flow
Common Stock
SEC:0001209191-21-065642·
€38,229455 shares@ €84.02080.0086% mcap0.8% of flow
Common Stock
SEC:0001209191-21-065642:0·
€89,8751,181 shares@ €76.10040.020% mcap3.8% of flow
Common Stock
SEC:0001209191-21-063142·
€89,8751,181 shares@ €76.10040.020% mcap1.8% of flow
Common Stock
SEC:0001209191-21-063142:0·
€48,192607 shares@ €79.3940.011% mcap2.0% of flow
Common Stock
SEC:0001209191-21-055088·
€48,192607 shares@ €79.3940.011% mcap1.0% of flow
Common Stock
SEC:0001209191-21-055088:0·
€135,8211,682 shares@ €80.74970.030% mcap5.7% of flow
Common Stock
SEC:0001209191-21-052302·
€135,8211,682 shares@ €80.74970.030% mcap2.8% of flow
Common Stock
SEC:0001209191-21-052302:0·
€399,7434,723 shares@ €84.63750.090% mcap16.8% of flow
Common Stock
SEC:0001209191-21-050044·
25 of 32 declarations
About Kim Paul
Kim Paul is the Chief Financial Officer of Fulgent Genetics, Inc.
